BioCentury
ARTICLE | Clinical News

Elafin regulatory update

April 1, 2013 7:00 AM UTC

Proteo said FDA granted Orphan Drug designation for Elafin to prevent inflammatory complications of transthoracic esophagectomy, a surgical procedure for esophageal cancer. Elafin has completed Phase ...